Macquarie University logoWe’re pleased to welcome Macquarie University’s Faculty of Medicine, Health & Human Sciences as a new member of CT:IQ. The Faculty is a leader in innovative, interdisciplinary research and education across medicine, health sciences, psychology, and human sciences, with a strong focus on real-world impact and improving health outcomes. Their work spans clinical research, […]
Uncategorised
CT:IQ is delighted to welcome AKTN to the Steering Committee
Based at the Princess Alexandra Hospital campus in Woolloongabba, the Australasian Kidney Trials Network (AKTN) operates under the Faculty of Health, Medicine and Behavioural Sciences at the University of Queensland. As a not-for-profit research organisation, AKTN designs, conducts and supports investigator-initiated clinical trials aimed at improving life for people living with Chronic Kidney Disease (CKD). […]
CT:IQ welcomes Central Coast Local Health District to the Steering Committee
CT:IQ is pleased to welcome Central Coast Local Health District (CCLHD) as the newest member of our Steering Committee. CCLHD provides high-quality public healthcare to the Central Coast community through a network of hospitals, healthcare centres, and community-based services. With a commitment to trusted care and better health for everyone, CCLHD supports a growing and ageing population of more than 350,000 […]
Central Pharmacy Logistics joins CT:IQ Steering Committee
CT:IQ is pleased to welcome Central Pharmacy Logistics (CPL) Australia as the newest member of our Steering Committee. CPL is a licenced Direct to Patient Clinical Trials solutions service, supporting the decentralised model of clinical trials. The organisation provides comprehensive project management for each patient—supporting nursing in the home to administer Investigational Medicinal Products and collect biological samples when required. […]
CT:IQ Welcomes Northern Sydney Local Health District as a New Member
CT:IQ is pleased to welcome Northern Sydney Local Health District (NSLHD) as our newest Steering Committee member. Royal North Shore (RNSH), Hornsby Ku-Ring-Gai, Ryde, Macquarie and Mona Vale hospitals, provide a wide range of complex and high-quality clinical services to patients from across New South Wales. Through NORTH Sydney Trials and Research (NORTH STAR), clinical […]
CT:IQ Welcomes Alexion to the Steering Committee
We are delighted to announce that Alexion, AstraZeneca Rare Disease, ANZ has joined CTIQ’s Steering Committee as our newest member. Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and delivery of life-changing medicines. A pioneering leader in rare disease for more than three decades, […]
Safer Care Victoria joins CT:IQ
We’re thrilled to announce the newest member to CT:IQ, Safer Care Victoria. Dedicated to enhancing healthcare quality and safety, Safer Care Victoria works tirelessly to prevent patient harm, identify and deliver service improvements, and engage with consumers. With their vision of outstanding healthcare for all Victorians, and a commitment to collaboration and innovation, they bring […]
CT:IQ welcomes newest Steering Committee Member, Fortrea
CT:IQ is delighted to announce the addition of Contract Research Organisation (CRO) Fortrea to our Steering Committee. Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. Fortrea partners with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing […]